Literature DB >> 31357749

β-Amyrin Ameliorates Alzheimer's Disease-Like Aberrant Synaptic Plasticity in the Mouse Hippocampus.

Hye Jin Park1, Huiyoung Kwon1, Ji Hye Lee2, Eunbi Cho1, Young Choon Lee1,3, Minho Moon4, Mira Jun3,5, Dong Hyun Kim1,3, Ji Wook Jung6.   

Abstract

Alzheimer's disease (AD) is a progressive and most frequently diagnosed neurodegenerative disorder. However, there is still no drug preventing the progress of this disorder. β-Amyrin, an ingredient of the surface wax of tomato fruit and dandelion coffee, is previously reported to ameliorate memory impairment induced by cholinergic dysfunction. Therefore, we tested whether β-amyrin can prevent AD-like pathology. β-Amyrin blocked amyloid β (Aβ)-induced long-term potentiation (LTP) impairment in the hippocampal slices. Moreover, β-amyrin improved Aβ-induced suppression of phosphatidylinositol-3-kinase (PI3K)/Akt signaling. LY294002, a PI3K inhibitor, blocked the effect of β-amyrin on Aβ-induced LTP impairment. In in vivo experiments, we observed that β-amyrin ameliorated object recognition memory deficit in Aβ-injected AD mice model. Moreover, neurogenesis impairments induced by Aβ was improved by β-amyrin treatment. Taken together, β-amyrin might be a good candidate of treatment or supplement for AD patients.

Entities:  

Keywords:  Alzheimer's disease; Amyloid β; Synaptic plasticity; β-amyrin

Year:  2019        PMID: 31357749     DOI: 10.4062/biomolther.2019.024

Source DB:  PubMed          Journal:  Biomol Ther (Seoul)        ISSN: 1976-9148            Impact factor:   4.634


  1 in total

Review 1.  Role of Cholinergic Signaling in Alzheimer's Disease.

Authors:  Zhi-Ru Chen; Jia-Bao Huang; Shu-Long Yang; Fen-Fang Hong
Journal:  Molecules       Date:  2022-03-10       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.